Zydus Lifesciences has secured final approval from the UA Food and Drug Administration (FDA) for Estradiol Transdermal System USP, 0.014 mg/day. The approved product which is to be used weekly is the generic version of Menostar Transdermal System and is approved for preventing postmenopausal osteoporosis. Zydus Lifesciences will manufacture the drug at its formulation manufacturing […]
Zydus Lifesciences (previously Cadila Healthcare) has secured final approval for Estradiol Transdermal System USP, 0.025 mg/day, 0.0375 mg/day, 0.05 mg/day, 0.075 mg/day, and 0.1 mg/day from the US Food and Drug Administration (FDA). The approved product is a generic version of Vivelle-Dot Transdermal System. Estradiol Transdermal System has FDA approval for the treatment of moderate […]
